Katarina Chlebova

Katarina Chlebova

Auto-generated profile, based on publicly available information

Katarina Chlebova

Department of Infectious Diseases and Preventive Medicine, Veterinary Research Institute, Hudcova 296/70, 62100 Brno, Czech Republic

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2014 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
MVMonika Vícenová
Monika Vícenová
KNKaterina Nechvatalova
Katerina Nechvatalova
KCKatarina Chlebova
Katarina Chlebova
ZKZdenka Kucerova
Zdenka Kucerova
LLLenka Leva
Lenka Leva
MFMartin Faldyna
Martin Faldyna
This study aims to investigate the anti-inflammatory effect of biologically active phospholipids (BAP) used in preparations for clinical practice in humans. Until date, except anti-neoplastic ability, little is known about anti-inflammatory property of the phospholipids. While the course of bacterially induced acute pneumonia and markers of inflammation were studied in in vivo system in pigs orally supplemented with BAP, the pro- and anti-inflammatory response of lipopolysaccharide-stimulated porcine monocyte-derived macrophages to 24 h- and 48 h-treatmeant by BAP was investigated in in vitro system. In vivo, the animal health status was monitored and pro-inflammatory IL-1β and IL-8 in sera were detected by ELISA during the experiment, while bronchoalveolar lavage fluids (BALF) and the lungs were examined post-mortem. Total and differential counts of white blood cell (WBC) were determined in blood and BALF. In vitro, mRNA expression of pro-inflammatory (TNF-α, IL-1β, CXCL10) and anti-inflammatory (IL-10 and Arg1) cytokines, and level of activated caspase 1 and phosphorylated protein kinase C epsilon (pPKCϵ), were studied using qRT-PCR and Western blot, respectively. For the purposes of both systems, 6 animals were used in each of the BAP-supplemented and the control groups. In vivo, BAP had a positive influence on the course of the disease. The immunomodulatory effects of BAP were confirmed by lower levels of IL-1β, IL-8, and a lower WBC count in the supplemented group in comparison with the control group. A lower percentage of lung parenchyma was affected in the supplemented group comparing to the control group (on average, 4% and 34% of tissue, respectively). In vitro, BAP suppressed mRNA expression of mRNA for IL-10 and all pro-inflammatory cytokines tested. This down-regulation was dose- and time-dependent. Arg1 mRNA expression remained unaffected. Further dose- and time-dependent suppression of the activated caspase 1 and pPKCϵ was detected in macrophages when treated with BAP. Our results demonstrate that BAP has anti-inflammatory and immunomodulatory properties, thus emphasizing the potential of this compound as a natural healing agent.

6 February 2022 in Research in Veterinary Science
Verified
Journal Article
Closed access
ZOZrinka Oreskovic
Zrinka Oreskovic
LLLenka Levá
Lenka Levá
KCKatarina Chlebová
Katarina Chlebová
KHKarolina Hlavová
Karolina Hlavová
RTRadek Tesařík
Radek Tesařík
MFMartin Faldyna
Martin Faldyna